Abstract
The patient was a 76-year-old man with advanced gastric cancer located in cardia, and was diagnosed to have an invasion to diaphragma and multiple lymph node metastases. We treated successfully with 12-course of S-1 chemotherapy. But second primary gastric cancer was detected in antrum 26 months after primary therapy. We treated with S-1/paclitaxel ( PTX) combined chemotherapy. S-1 (80 mg/m2) was orally administered for 2 weeks followed by a week interval and PTX (50 mg/m2) was also administered days 1 and 8. One course of chemotherapy was 21 days. GIF and abdominal CT revealed complete response (CR) after 3 courses of chemotherapy. We are now going on 6 courses of chemotherapy and the patient did not experience any grade 3 adverse effects.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cardia*
-
Drug Combinations
-
Humans
-
Male
-
Neoplasm Recurrence, Local
-
Oxonic Acid / administration & dosage
-
Oxonic Acid / therapeutic use*
-
Paclitaxel / administration & dosage
-
Stomach Neoplasms / drug therapy*
-
Tegafur / administration & dosage
-
Tegafur / therapeutic use*
Substances
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents, Phytogenic
-
Drug Combinations
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid
-
Paclitaxel